热门解读｜Claudin 18.2

如您对以上三个克隆产物感兴味，欢送扫描下方二维码填写表单，我们将有专员与您尽快接洽！

若有须要，可随时接洽Abcam定制部分的司理薛晓波博士。

接洽方法

直线：021-20700508；

手机：18521516801（微信）；

邮箱：lambert.xue@abcam.com

参考文献

1. Tsukita， S.， Furuse， M. Itoh， M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2， 285-293， doi：10.1038/35067088 (2001).

2. Gunzel， D. Yu， A. S. Claudins and the modulation of tight junction permeability. Physiol Rev 93， 525-569， doi：10.1152/physrev.00019.2012

93/2/525 [pii] (2013).

3. Klamp， T. et al. Highly specific auto-antibodies against claudin-18 isoform 2 induced by a chimeric HBcAg virus-like particle vaccine kill tumor cells and inhibit the growth of lung metastases. Cancer Res 71， 516-527， doi：10.1158/0008-5472.CAN-10-2292 (2011).

4. Sahin， U. et al. Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clinical cancer research ： an official journal of the American Association for Cancer Research 14， 7624-7634， doi：10.1158/1078-0432.CCR-08-1547 (2008).

5. Sanada， Y. et al. Down-regulation of the claudin-18 gene， identified through serial analysis of gene expression data analysis， in gastric cancer with an intestinal . J Pathol 208， 633-642， doi：10.1002/path.1922 (2006).

6. Woll， S. et al. Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms. Int J Cancer 134， 731-739， doi：10.1002/ijc.28400 (2014).

7. Micke， P. et al. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. Int J Cancer 135， 2206-2214， doi：10.1002/ijc.28857 (2014).

8. Moentenich， V. et al. Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies. Oncol Lett 19， 3665-3670， doi：10.3892/ol.2020.11520 (2020).

9. Arnold， A. et al. Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas. Clin Transl Oncol， doi：10.1007/s12094-020-02380-0 (2020).

10. Singh， P.， Toom， S. Huang， Y. Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer. J Hematol Oncol 10， 105， doi：10.1186/s13045-017-0473-4 (2017).